Rockwell Medical (NASDAQ: RMTI) reported Q3 EPS of $0.09, $0.08 better than the analyst estimate of $0.01. Revenue for the quarter came in at $28.3 million versus the consensus estimate of $26.5 million.

GUIDANCE:

Rockwell Medical sees FY2024 revenue of $98-101 million, versus the consensus of $100.2 million.

For earnings history and earnings-related data on Rockwell Medical (RMTI) click here.